| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.21 | 8e-05 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0009 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.003 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.005 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.005 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |